Novel Immunological Aspects of Sirolimus as a New Targeted Therapy for COVID-19
Título
Novel Immunological Aspects of Sirolimus as a New Targeted Therapy for COVID-19
Autor
Mahshid Naserifar, Hesamoddin Hosseinjani
Descripción
No Abstract No Abstract No Abstract No Abstract
Fecha
2020
Materia
n/a
Identificador
10.18502/jpc.v8i3.4553
Fuente
Journal of Pharmaceutical Care
Editor
Research Center for Rational Use of Drugs (RCRUD)
Cobertura
Therapeutics. Pharmacology, Pharmacy and materia medica
Archivos
Colección
Citación
Mahshid Naserifar, Hesamoddin Hosseinjani, “Novel Immunological Aspects of Sirolimus as a New Targeted Therapy for COVID-19,” SOCICT Open, consulta 16 de abril de 2026, https://www.socictopen.socict.org/items/show/7505.
Position: 11109 (24 views)